GlassScriptPhysician profile
Samantha E Berg
NPI 1316494768
$2,510.06
in general payments reported to CMS, 2019-2025
28 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.76 · 2020: $382 · 2021: $324 · 2022: $677 · 2023: $319 · 2024: $387 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.96 | 2020-2023 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Daiichi Sankyo INC. | $248.42 | 2019-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $192.38 | 2022-2025 | |
| Astellas Pharma US INC | $185.66 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $171.15 | 2019-2023 | |
| Biogen, INC. | $129.65 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $119.10 | 2021-2025 | Paragard T 380a, Insorb |
| Hologic Sales and Service, LLC | $109.84 | 2022-2025 | Aptima |
| Myovant Sciences INC. | $109.04 | 2021-2022 | |
| Organon LLC | $106.13 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $95.46 | 2020-2024 | Ova1 |
| Therapeuticsmd, INC. | $90.88 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $84.03 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $75.84 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $67.20 | 2023-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.18 | 2022-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $46.78 | 2025 | Cologuard Collection Kit |
| Channel Medsystems, INC. | $46.46 | 2021-2022 | |
| Lupin INC. | $41.65 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $37.08 | 2019-2020 | |
| Millicent US INC | $34.54 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Lilly USA, LLC | $29.84 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $17.57 | 2020 | |
| Merck Sharp & Dohme LLC | $16.70 | 2019 | |
| Mission Pharmacal Company | $15.72 | 2020 | |
| Amag Pharmaceuticals, INC. | $14.21 | 2020 | |
| Ascend Therapeutics US, LLC | $13.25 | 2022 | |
| Meditrina | $5.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.